Skip to content

Effect of vitamin D on intensity of dysmenorrhea

Investigating the effect of low dose vitamin D on intensity of dysmenorrhea

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180218038789N3
Enrollment
92
Registered
2020-09-15
Start date
2020-10-22
Completion date
Unknown
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary dysmenorrhea. Primary dysmenorrhea

Interventions

Intervention 1: Intervention group: Capsule of Vitamin D 1000 IU// These capsules will be provided by Nanohiat Pharmaceutical Company. Vitamin D capsules with a dose of 1000 units are prepared for dai

Sponsors

Qazvin University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Moderate to severe primary dysmenorrhea (score above 4 based on visual pain scale) Being Single Being at reproductive ages (18 to 35 years) Student of Qazvin University of Medical Sciences Willingness to participate in the study

Exclusion criteria

Exclusion criteria: Presence of secondary dysmenorrhea and its underlying factors such as history of endometriosis, adenomyosis, subacute endometritis, pelvic inflammatory disease, copper intrauterine devices, ovarian cysts, congenital pelvic malformations and cervical stenosis based on individual statement Concurrent use of corticosteroids, anticonvulsants, anti-TB, anti-hypertension, which interfere with the absorption of vitamin D. Use vitamin D or calcium supplements Probability of graduation during the follow-up period History of known mental illness based on individual statement Drug addiction based on self disclosure

Design outcomes

Primary

MeasureTime frame
Intensity of dysmenorrhea pain. Timepoint: Before, Immediately, 1, 3, 6 months after intervention. Method of measurement: Visual analogue scale.

Secondary

MeasureTime frame
Duration of dysmenorrhea pain. Timepoint: Before, immediately, 1, 3 and 6 months after the intervention. Method of measurement: Individual report of pain duration by day.;Need to use pain killer. Timepoint: Before, immediately, 1, 3 and 6 months after the intervention. Method of measurement: Individual report of need to use pain killer.;Menstrual distress. Timepoint: Before, immediately, 1, 3 and 6 months after the intervention. Method of measurement: Moos questionnaire of menstrual distress.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactZainab Alimoradi

Qazvin University of Medical Sciences

zainabalimoradi.sbmu.ac.ir@gmail.com+98 28 3333 6002

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026